-
Founded in:
1991-07-12 -
Country:
China -
Address:
No. 1 Huizhong Road, Nanjing Economic and Technological Development Zone -
Tax NO.:
9132019213490905XY -
Registered Funds:
61.7764 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| FTIBAMZONE |
It has anti-Chlamydia trachomatis and anti-herpes virus activity. Its mechanism of action is mainly to inhibit viral DNA and early protein synthesis. It has a certain antifungal effect on dermatophytes.
More
It has anti-Chlamydia trachomatis and anti-herpes virus activity. Its mechanism of action is mainly to inhibit viral DNA and early protein synthesis. It has a certain antifungal effect on dermatophytes. |
210165-00-7 | 3 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Berberine hydrochloride |
It has only a weak antibacterial effect on bacteria, but is effective against intestinal infections caused by Shigella dysenteriae and Escherichia coli.
More
It has only a weak antibacterial effect on bacteria, but is effective against intestinal infections caused by Shigella dysenteriae and Escherichia coli. |
633-65-8 | 46 | |
| Diphenhydramine and aminophylline combination |
It has antihistamine effect, can inhibit vascular exudation, reduce tissue edema, and has sedative and antiemetic effects. After oral administration, it is quickly and completely absorbed in the gastrointestinal tract.
More
It has antihistamine effect, can inhibit vascular exudation, reduce tissue edema, and has sedative and antiemetic effects. After oral administration, it is quickly and completely absorbed in the gastrointestinal tract. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Licorice extract |
Protective expectorant
More
Protective expectorant |
68916-91-6 | 0 | |
| POTASSIUM ANTIMONY TARTRATE |
Nausea expectorants
More
Nausea expectorants |
16039-64-8 | 0 | |
| Compound camphor tincture |
Cough suppressants
More
Cough suppressants |
0 | ||
| Glycerol |
Keep the preparation stable and prevent precipitation and precipitation
More
Keep the preparation stable and prevent precipitation and precipitation |
56-81-5 | 61 | |
| Concentrated ammonia solution |
Keep the preparation stable and prevent precipitation and precipitation
More
Keep the preparation stable and prevent precipitation and precipitation |
0 | ||
| Ethanol |
Keep the preparation stable and prevent precipitation and precipitation
More
Keep the preparation stable and prevent precipitation and precipitation |
64-17-5 | 89 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nifedipine |
Nifedipine is a dihydropyridine calcium antagonist that selectively inhibits the transmembrane transport of calcium ions into myocardial cells and smooth muscle cells, and inhibits the release of calcium ions from intracellular reservoirs without changing the plasma calcium ion concentration. It can simultaneously relax the coronary arteries in the normal blood supply area and the ischemic area, antagonize spontaneous or ergonovine-induced coronary artery spasm, increase the delivery of myocardial oxygen in patients with coronary artery spasm, and relieve and prevent coronary artery spasm. It can also inhibit myocardial contraction, reduce myocardial metabolism, and reduce myocardial oxygen consumption. On the other hand, it can relax peripheral resistance vessels, reduce peripheral resistance, reduce systolic and diastolic blood pressure, and reduce cardiac afterload. It can delay the sinus node function and atrioventricular conduction of isolated hearts; electrophysiological studies on whole animals and humans have not found that this product has the effect of delaying atrioventricular conduction, prolonging the recovery time of the sinus node, and slowing down the sinus node rate.
More
Nifedipine is a dihydropyridine calcium antagonist that selectively inhibits the transmembrane transport of calcium ions into myocardial cells and smooth muscle cells, and inhibits the release of calcium ions from intracellular reservoirs without changing the plasma calcium ion concentration. It can simultaneously relax the coronary arteries in the normal blood supply area and the ischemic area, antagonize spontaneous or ergonovine-induced coronary artery spasm, increase the delivery of myocardial oxygen in patients with coronary artery spasm, and relieve and prevent coronary artery spasm. It can also inhibit myocardial contraction, reduce myocardial metabolism, and reduce myocardial oxygen consumption. On the other hand, it can relax peripheral resistance vessels, reduce peripheral resistance, reduce systolic and diastolic blood pressure, and reduce cardiac afterload. It can delay the sinus node function and atrioventricular conduction of isolated hearts; electrophysiological studies on whole animals and humans have not found that this product has the effect of delaying atrioventricular conduction, prolonging the recovery time of the sinus node, and slowing down the sinus node rate. |
21829-25-4 | 74 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Trimethoprim |
Trimethoprim (TMP) is an antibacterial agent, a lipophilic weak base, and its chemical structure belongs to the pyrimethamine class. It has antibacterial activity against Escherichia coli, Klebsiella, Proteus mirabilis, Salmonella, and Shigella. It has no obvious antibacterial effect on Streptococcus pneumoniae, Neisseria gonorrhoeae, and Neisseria meningitidis, and has no effect on Pseudomonas aeruginosa. The mechanism of action of this product is to interfere with bacterial folic acid metabolism. It mainly selectively inhibits the activity of bacterial dihydrofolate reductase, so that dihydrofolate cannot be reduced to tetrahydrofolate, and synthetic folic acid is the main component of nucleic acid biosynthesis. Therefore, this product prevents the synthesis of bacterial nucleic acids and proteins, and the binding of this product to bacterial dihydrofolate reductase is 50,000 to 60,000 times tighter than that to mammalian enzymes. The combination of this product and sulfonamides can double block the bacterial folic acid synthesis metabolism, have a synergistic effect, enhance the antibacterial activity of sulfonamides, and convert the antibacterial effect into a bactericidal effect, reducing the production of drug-resistant strains.
More
Trimethoprim (TMP) is an antibacterial agent, a lipophilic weak base, and its chemical structure belongs to the pyrimethamine class. It has antibacterial activity against Escherichia coli, Klebsiella, Proteus mirabilis, Salmonella, and Shigella. It has no obvious antibacterial effect on Streptococcus pneumoniae, Neisseria gonorrhoeae, and Neisseria meningitidis, and has no effect on Pseudomonas aeruginosa. The mechanism of action of this product is to interfere with bacterial folic acid metabolism. It mainly selectively inhibits the activity of bacterial dihydrofolate reductase, so that dihydrofolate cannot be reduced to tetrahydrofolate, and synthetic folic acid is the main component of nucleic acid biosynthesis. Therefore, this product prevents the synthesis of bacterial nucleic acids and proteins, and the binding of this product to bacterial dihydrofolate reductase is 50,000 to 60,000 times tighter than that to mammalian enzymes. The combination of this product and sulfonamides can double block the bacterial folic acid synthesis metabolism, have a synergistic effect, enhance the antibacterial activity of sulfonamides, and convert the antibacterial effect into a bactericidal effect, reducing the production of drug-resistant strains. |
738-70-5 | 44 |